Clinical trial

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals'…

NCT00307567 · GlaxoSmithKline, Industry · Completed

Key facts

NCT number NCT00307567
Title Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488
Official title A Phase II, Multicentre Booster Study to Evaluate Booster Vaccination With GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or to Evaluate the Immune Memory Following the Administration of a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children, Previously Vaccinated in…
Lead sponsor GlaxoSmithKline, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Acellular Pertussis, Tetanus, Hepatitis B, Diphtheria, Haemophilus Influenzae Type b, Poliomyelitis
Intervention type Biological
Interventions Pneumococcal (vaccine)
Enrollment 689
Start date Nov 1, 2005
Completion Mar 1, 2006
First posted Mar 28, 2006
Last update posted Sep 23, 2016
Countries Germany

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies